JPS5823399B2 - Phenoxy Amino Probanol - Google Patents
Phenoxy Amino ProbanolInfo
- Publication number
- JPS5823399B2 JPS5823399B2 JP48094977A JP9497773A JPS5823399B2 JP S5823399 B2 JPS5823399 B2 JP S5823399B2 JP 48094977 A JP48094977 A JP 48094977A JP 9497773 A JP9497773 A JP 9497773A JP S5823399 B2 JPS5823399 B2 JP S5823399B2
- Authority
- JP
- Japan
- Prior art keywords
- benzene
- acid
- phenoxy
- ether
- general formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Description
【発明の詳細な説明】
本発明は、一般式
(式中、Rはテトラヒドロフルフリルまたはフルフリル
を示す。DETAILED DESCRIPTION OF THE INVENTION The present invention is based on the general formula (wherein R represents tetrahydrofurfuryl or furfuryl).
)で表わされる新規なフェノキシ・アミン・プロパツー
ル誘導体およびそれらの酸付加塩の製造法に関する。) and a method for producing their acid addition salts.
一般式〔1〕の目的化合物は、本発明に従って、次の■
、■の方法で製造される。According to the present invention, the target compound of general formula [1] is as follows:
, manufactured by the method of ■.
方法■
一般式
で表わされる化合物と2.2.6.6−チトラメチルピ
ペリジンとの反応。Method ■ Reaction of the compound represented by the general formula with 2.2.6.6-titramethylpiperidine.
ここでYは−CH−CH2または−CH(OH)−CH
2−(ハロゲン)を示す。where Y is -CH-CH2 or -CH(OH)-CH
2-(halogen).
上記の方法■の反応は溶媒の存在下に行ない得る。The reaction in method (1) above may be carried out in the presence of a solvent.
溶媒としては、ジエチルエーテル、ジオキサン、テトラ
ヒドロフランなどのエーテル類、メタノール、エタノー
ル、フロパノール、インプロパツール、アミルアルコー
ル、イソアミルアルコールなどのアルコール類、ベンゼ
ン、トルエン、キシレンなどの芳香族炭化水素類、水、
ジメチルホルムアミド、ジメチルスルホキサイド、その
他反応を阻害しない溶媒がいずれも用いられる。Examples of solvents include ethers such as diethyl ether, dioxane, and tetrahydrofuran, alcohols such as methanol, ethanol, furopanol, impropatol, amyl alcohol, and isoamyl alcohol, aromatic hydrocarbons such as benzene, toluene, and xylene, water,
Dimethylformamide, dimethyl sulfoxide, and any other solvent that does not inhibit the reaction may be used.
なかでも好ましいのはメタノール、エタノールなどであ
る。Among them, methanol, ethanol, etc. are preferred.
Yが−CH(0■()−〇H2−(ハロゲン)である式
(U )の化合物2.2.6.6−チトラメチルピペリ
ジンを反応させるときには、後者を過剰に用いて脱酸剤
としてもよく、炭酸カリウム、炭酸ナトリウムなどの炭
酸アルカリ、苛性カリ、苛性ソーダなどの苛性アルカリ
土類金属ナトリウム、水素化ナトリウム、ナトリウムア
ミドなど、またはトリエチルアミン、ピリジンなどの第
3級アミンを脱酸剤として用いてもよい。When reacting the compound 2.2.6.6-titramethylpiperidine of formula (U) in which Y is -CH(0■()-〇H2-(halogen)), the latter is used in excess as a deoxidizing agent. Also, alkali carbonates such as potassium carbonate and sodium carbonate, caustic alkaline earth metal sodiums such as caustic potash and caustic soda, sodium hydride, sodium amide, etc., or tertiary amines such as triethylamine and pyridine are used as deoxidizing agents. Good too.
反応は一般に室温でも進むが、使用溶媒の沸点程度まで
加熱してもよい。Although the reaction generally proceeds at room temperature, it may be heated to about the boiling point of the solvent used.
で表わされる化合物と一般式 で表わされる化合物とを反応させる方法。Compound and general formula represented by A method of reacting with a compound represented by
ここでZはハロゲン原子(塩素、臭素など)、アリール
−またはアルキル−スルホニルオキシ(p−トリルスル
ホニルオキシ、メチルスルホニルオキシなど)などの反
応性の原子または基を示す。Here, Z represents a reactive atom or group such as a halogen atom (chlorine, bromine, etc.), aryl- or alkyl-sulfonyloxy (p-tolylsulfonyloxy, methylsulfonyloxy, etc.).
上記の方法■の反応は通常方法■で述べた如き溶媒中で
、脱酸剤の存在下に行なわれる。The reaction in method (1) above is usually carried out in a solvent as described in method (2) in the presence of a deoxidizing agent.
反応は室温でも進行するが、使用溶媒の還流下に実施す
るのが好適である。Although the reaction proceeds at room temperature, it is preferably carried out under reflux of the solvent used.
原料化合物はたとえば次に記載の方法で調製される。The raw material compound is prepared, for example, by the method described below.
■、原料化合物〔皿〕の調製
調製例
ピロカテコール12gをアセトン80rrLlに溶解し
、炭酸カリウム16gを加えた後、撹拌下に、室温でフ
ルフリルクロライド14gを滴下する。(2) Preparation of raw material compound [dish] Preparation example 12 g of pyrocatechol was dissolved in 80 rrLl of acetone, 16 g of potassium carbonate was added, and 14 g of furfuryl chloride was added dropwise at room temperature while stirring.
滴下後、除々に温度を上げ、6時間撹拌還流する。After the dropwise addition, the temperature was gradually raised and the mixture was stirred and refluxed for 6 hours.
今後、不溶物を戸去し、減圧下に濃縮し、残有に水を加
えて、ベンゼン150111で抽出する。Thereafter, insoluble matter is removed, concentrated under reduced pressure, water is added to the residue, and extracted with benzene 150111.
ベンゼン層を5係水酸化ナトリウム水溶液で抽出する。The benzene layer is extracted with a 5-functional aqueous sodium hydroxide solution.
水層を10係塩酸水で酸性にすると油状物が遊離する。When the aqueous layer is made acidic with 10% hydrochloric acid water, an oily substance is liberated.
再びベンゼン]、 50TLlで抽出する。ベンゼン層
を水100ml、次いで5係炭素水素すl−IJウム水
溶液50〃llで2回洗う。benzene] and extracted with 50 TLl. The benzene layer was washed twice with 100 ml of water and then with 50 ml of an aqueous solution of 5-functional carbon hydrogen sulfur-IJium.
ベンゼン層を無水硫酸マグネシウムで乾燥後、ベンゼン
を留去する。After drying the benzene layer over anhydrous magnesium sulfate, the benzene is distilled off.
1)
・残留油状物を蒸留精製すると、沸点105〜1120
C10,ObnmHgの2−(フルフリルオキシ)フェ
ノール10gが得られる。1) - When the residual oil is purified by distillation, the boiling point is 105-1120
10 g of 2-(furfuryloxy)phenol of C10, ObnmHg are obtained.
2、原料化合物〔■〕の調製
調製例
2−(フルフリルオキシ)フェノール40gを、水酸化
カリウム13gの水20071Ll溶液に溶かし、室温
でエピクロルヒドリン21.5gを加え、室温で8時間
撹拌する。2. Preparation of raw material compound [■] Preparation Example 2 - Dissolve 40 g of (furfuryloxy)phenol in a solution of 13 g of potassium hydroxide in 20,071 L of water, add 21.5 g of epichlorohydrin at room temperature, and stir at room temperature for 8 hours.
反応後、分離する油状物をベンゼン200m1で抽出し
、ベンゼン層を水洗後、無水硫酸マグネシウムで乾燥し
、ベンゼンを留去する。After the reaction, the separated oil is extracted with 200 ml of benzene, the benzene layer is washed with water, dried over anhydrous magnesium sulfate, and the benzene is distilled off.
残留油状物を蒸留精製すると、沸点1522)
;〜168°C10,3mmHgの1,2−エポキシ−
5−(2−(フルフリルオキシ)フェノキシJ フ0/
々ン21. gが得られる。When the residual oil is purified by distillation, it yields 1,2-epoxy with a boiling point of 1522);
5-(2-(furfuryloxy)phenoxy J F0/
21. g is obtained.
同様にして、沸点150〜162°C10,5〜0.7
mmHgの1,2−エポキシ−3−〔2−(テトラヒド
ロフルフリルオキシ)フェノキシ〕プロパンが得られる
。Similarly, boiling point 150-162°C 10,5-0.7
mmHg of 1,2-epoxy-3-[2-(tetrahydrofurfuryloxy)phenoxy]propane is obtained.
調製例
2−(テトラヒドロフルフリルオキシ)フェノール5g
1エピクロルヒドリン10g1触媒としてのピペリジン
0.1gの混液を70〜80℃で3時間加熱撹拌する。Preparation Example 2 - (Tetrahydrofurfuryloxy)phenol 5g
1 A mixture of 10 g of epichlorohydrin and 0.1 g of piperidine as a catalyst is heated and stirred at 70 to 80° C. for 3 hours.
反応後、0.O3mmHgの減圧下で反応液を濃縮する
と、油状物として、1−クロル−3−〔2−(テトラヒ
ドロフルフリルオキシ)フェノキシクー2−プロパツー
ル7.5gが得られる。After reaction, 0. The reaction solution is concentrated under reduced pressure of 03 mmHg to obtain 7.5 g of 1-chloro-3-[2-(tetrahydrofurfuryloxy)phenoxycou-2-propatol as an oil.
3、 2.2.6.6−チトラメチルピペリジンの調製
本化合物はアルドリッチ社から市販されている。3. Preparation of 2.2.6.6-Titramethylpiperidine This compound is commercially available from Aldrich.
その合成法はパイルシュフィンのノットブック並。The synthesis method is comparable to Pyleshfin's knot book.
129に記載されており、沸点152°C2n201.
4440である。129, with a boiling point of 152°C2n201.
It is 4440.
4、原料化合物(IV)の調製
調製例
2、2.6.6−チトラメチルピペリジン1.41gの
エーテル1om1.溶液に、エピクロルヒドリン0.9
3gを水冷下に加える。4. Preparation of raw material compound (IV) Preparation example 2, 2.6.6-Titramethylpiperidine 1.41 g ether 1 om1. Add 0.9 of epichlorohydrin to the solution.
Add 3g under water cooling.
暫くして減圧下にエーテルを留去すると、油状物として
、■−クロルー3−(2,2,6,6−チトラメチルピ
ペリジノ)−2−プロパツール2.35gが得られる。After a while, the ether was distilled off under reduced pressure to obtain 2.35 g of -chloro-3-(2,2,6,6-titramethylpiperidino)-2-propatol as an oil.
本市は不安定なために、そのまま次の反応に用いる。Since Motoichi is unstable, it will be used as is for the next reaction.
上記方法で製造される化合物〔1〕は通常の方法で、酸
付加塩へ変換することが出来る。Compound [1] produced by the above method can be converted into an acid addition salt by a conventional method.
酸付加塩を製造するために用いる酸としては、塩酸、硫
酸、硝酸、リン酸、臭化水素酸などの無機酸、蓚酸、マ
レイン酸、フマール酸、リンゴ酸、o −(p−ヒドロ
キシベンゾイル)安息香酸、フェノールフタリンなどの
有機酸が挙げられる。Acids used to produce acid addition salts include inorganic acids such as hydrochloric acid, sulfuric acid, nitric acid, phosphoric acid, and hydrobromic acid, oxalic acid, maleic acid, fumaric acid, malic acid, and o-(p-hydroxybenzoyl). Examples include organic acids such as benzoic acid and phenolphthalin.
一般式〔■〕で表わされる化合物は不斉炭素を有する為
、光学活性体かラセミ体であり得る。Since the compound represented by the general formula [■] has an asymmetric carbon, it can be an optically active form or a racemic form.
分子内に2個の不斉炭素をもつラセミ体は2種のラセミ
シアストレオマーに分割することが出来る。A racemate with two asymmetric carbon atoms in the molecule can be divided into two racemic streomers.
また、ラセミ体は通常よく知られた方法により、光学的
に活性なエナンチオマーや、ジアステレオマーに分割す
ることが出来る。Furthermore, racemates can be usually separated into optically active enantiomers and diastereomers by well-known methods.
一般式〔1〕のフェノキシ・アミン・プロパツール誘導
体およびそれらの酸付加塩は局所麻酔剤、抗不整脈剤と
して有用な化合物である。Phenoxy amine propatool derivatives of general formula [1] and acid addition salts thereof are useful compounds as local anesthetics and antiarrhythmic agents.
実施例 1
■、2−エポキシー5−(:2−(テトラヒドロフルフ
リルオキシ)フェノキシ〕プロパン5.0gをブタノー
ル357711に溶かし、2.2.6.6−チトラメチ
ルピペリジン3.1g、水1滴を加えて、9時間還流加
熱する。Example 1 ■, 5.0 g of 2-epoxy 5-(:2-(tetrahydrofurfuryloxy)phenoxy)propane was dissolved in butanol 357711, 3.1 g of 2.2.6.6-titramethylpiperidine, and 1 drop of water. and heated under reflux for 9 hours.
ブタノールを留去し、残有をベンゼア 150mk溶カ
シ、5係塩酸10077Llテ抽出する。The butanol was distilled off, and the residue was extracted with 150 mK of benzea and 10,077 L of hydrochloric acid.
水層を炭酸カリウムで中和後、さらに水酸化カリウムで
アルカリ性にし、遊離する油状物をベンゼン200TI
Llで抽出する。After neutralizing the aqueous layer with potassium carbonate, it is further made alkaline with potassium hydroxide, and the liberated oil is mixed with benzene 200TI.
Extract with Ll.
ベンゼン抽出液を水洗後、無水硫酸マグネシウムで乾燥
する。After washing the benzene extract with water, it is dried over anhydrous magnesium sulfate.
ベンゼンを留去し、残留物を蒸留精製すると、沸点20
0〜227°G、10.7mmHgの1−(2,2,6
,6−チトラメチルピペリジノ)−3−(2−(テトラ
ヒドロフルフリルオキシ)フェノキシシー2−プロパツ
ールが6.1g得られる。When benzene is distilled off and the residue is purified by distillation, the boiling point is 20
1-(2,2,6
, 6-titramethylpiperidino)-3-(2-(tetrahydrofurfuryloxy)phenoxy-2-propatool) is obtained.
本市のフマール酸塩は融点140〜142.5°C(エ
タノール−イソプロピルエーテルから再結晶)を示す。The fumarate salt of Motoichi has a melting point of 140-142.5°C (recrystallized from ethanol-isopropyl ether).
実施例 2
1−クロル−3−〔2−(テトラヒドロフルフリルオキ
シ)フェノキシシー2−プロパツール5.7gをエタノ
ール55m1に溶カシ、2.2.6.6−チトラメチル
ピペリジン6.2gを加えて、水浴上20時間加熱還流
する。Example 2 5.7 g of 1-chloro-3-[2-(tetrahydrofurfuryloxy)phenoxy-2-propatol was dissolved in 55 ml of ethanol, and 6.2 g of 2.2.6.6-titramethylpiperidine was added. Heat under reflux on a water bath for 20 hours.
エタノールを留去し、残有をエーテルに溶かし、5%塩
酸150m1で抽出する。Ethanol is distilled off, the residue is dissolved in ether, and extracted with 150 ml of 5% hydrochloric acid.
水層を水酸化すトリウムでアルカリ性にし、遊離する油
状物をエーテルで2回抽出する。The aqueous layer is made alkaline with thorium hydroxide and the liberated oil is extracted twice with ether.
エーテル層を無水炭酸カリウムで乾燥後、エーテルを留
去し、残留物を蒸留精製すると、沸点200〜2270
C/ 0.7 mmHgの1−(2,2,6,6−チト
ラメチルピペリジノ)−3−〔2−(テトラヒドロフル
フリルオキシ)フェノキシヨー2−プ0/クノールが6
65g得られる。After drying the ether layer over anhydrous potassium carbonate, the ether is distilled off and the residue is purified by distillation, resulting in a boiling point of 200-2270.
C/0.7 mmHg 1-(2,2,6,6-titramethylpiperidino)-3-[2-(tetrahydrofurfuryloxy)phenoxyio2-p0/Knorr 6
65g is obtained.
実施例 3
2−(テI・ラヒドロフルフリルオキシ)フェノール3
9g1無水炭酸カリウム2.8g、アセトン75TLl
の混合液中に、撹拌しなから1−クロル−5−(2,2
,6,6−チトラメチルピペリジノ)−2=プロパツー
ル5.2gを加えて、20時間撹拌しながら加熱還流す
る。Example 3 2-(TeI-lahydrofurfuryloxy)phenol 3
9g 1 anhydrous potassium carbonate 2.8g, acetone 75TLl
1-chloro-5-(2,2
, 6,6-titramethylpiperidino)-2=5.2 g of propatool was added, and the mixture was heated under reflux with stirring for 20 hours.
反応後、不溶物を炉去し、P液を減圧下に濃縮する。After the reaction, insoluble materials are removed from the furnace and the P solution is concentrated under reduced pressure.
残有をエーテルに溶かし、5多塩酸15oml!で抽出
する。Dissolve the remaining residue in ether and 15 oml of 5 polyhydrochloric acid! Extract with
水層を水酸化ナトリウムでアルカリ性にし、遊離する油
状物をエーテルで2回抽出する。The aqueous layer is made alkaline with sodium hydroxide and the liberated oil is extracted twice with ether.
エーテル層を無水炭酸カリウムで乾燥後、エーテルを留
去し、残留物を蒸留精製すると、沸点200〜227°
C10,7mmHgの1−(2,2,6,6−チトラメ
チルピペリジノ)−3−〔2−(テトラヒドロフルフリ
ルオキシ)フェノキシシー2−プロパツールが5.8g
得られる。After drying the ether layer over anhydrous potassium carbonate, the ether is distilled off and the residue is purified by distillation, resulting in a boiling point of 200-227°.
5.8 g of 1-(2,2,6,6-titramethylpiperidino)-3-[2-(tetrahydrofurfuryloxy)phenoxy-2-propatol at C10.7 mmHg
can get.
上記実施例1〜3と同様にして、1− (2,2,6,
6−チトラメチルピペリジン)−3−1: :2−(フ
ルフリルオキシ)フェノキシシー2−プロパツールが得
られ、そのフマール酸塩は融点170〜172°Cを示
す。1- (2, 2, 6,
6-titramethylpiperidine)-3-1: :2-(furfuryloxy)phenoxy-2-propatur is obtained, the fumarate salt of which exhibits a melting point of 170-172°C.
Claims (1)
を、Yは−CH−CH2または−CH(OH)−CH2
−(ハロゲン)を示す。 )で表わされる化合物と2.2.6.6.−テトラメチ
ルピペリジンとを反応させることを特徴とする、一般式 (式中、Rは前記と同様である。 )で表わされる化合物の製造法。 一般式 (式中、Rはテトラヒドロフルフリルまたはフルフリル
を示す。 )で表わされる化合物と一般式 (式中、Zは反応性の原子または基を示す。 )で表わされる化合物と反応させることを特徴とする、
一般式 (式中、Rは前記と同義である。 で表わされる化合物の製造法。[Claims] 1 General formula (wherein R is tetrahydrofurfuryl or furfuryl, Y is -CH-CH2 or -CH(OH)-CH2
- (halogen). ) and 2.2.6.6. -Tetramethylpiperidine. A compound represented by the general formula (wherein R represents tetrahydrofurfuryl or furfuryl) is reacted with a compound represented by the general formula (wherein Z represents a reactive atom or group). and
A method for producing a compound represented by the general formula (wherein R has the same meaning as above).
Priority Applications (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP48094977A JPS5823399B2 (en) | 1973-08-23 | 1973-08-23 | Phenoxy Amino Probanol |
| CA207,061A CA1046066A (en) | 1973-08-23 | 1974-08-14 | 1-(methylated piperidino (and pyrrolidin -1-yl)-3-(substituted phenoxy)-2-propanols |
| BE147714A BE818965A (en) | 1973-08-23 | 1974-08-16 | 1-(heterocyclic amino)-3-phenoxy-propanols-2 - anti-arrhythmics, local anaesthetics, analgesics, and anti-secretories |
| AT680074A AT343658B (en) | 1973-08-23 | 1974-08-21 | PROCESS FOR THE PREPARATION OF NEW PIPERIDINE AND PYRROLIDINE COMPOUNDS AND THEIR SALTS |
| GB3702774A GB1430719A (en) | 1973-08-23 | 1974-08-22 | 3-substituted phenoxy-2-propanols and pharmaceutical compositions containing them |
| SE7410696A SE411672B (en) | 1973-08-23 | 1974-08-22 | PROCEDURE FOR THE PREPARATION OF 1- (METHYLATED PIPERIDINO (AND PYRROLIDIN-1-YL)) - 3- (SUBSTITUTED PHENOXY) -2-PROPANOLS WITH THERAPEUTIC EFFECT |
| US05/499,948 US3954776A (en) | 1973-08-23 | 1974-08-23 | 1-[Methylated piperidino(and pyrrolidin-1-yl)]-3-(substituted phenoxy)-2propanols |
| DE2440541A DE2440541A1 (en) | 1973-08-23 | 1974-08-23 | 1-PIPERIDINO- OR 1-PYRROLIDINO-3PHENOXY-2-PROPANOLS, THE METHOD FOR THEIR MANUFACTURING AND MEDICINAL PRODUCTS |
| FR7428924A FR2241306B1 (en) | 1973-08-23 | 1974-08-23 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP48094977A JPS5823399B2 (en) | 1973-08-23 | 1973-08-23 | Phenoxy Amino Probanol |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5046657A JPS5046657A (en) | 1975-04-25 |
| JPS5823399B2 true JPS5823399B2 (en) | 1983-05-14 |
Family
ID=14124954
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP48094977A Expired JPS5823399B2 (en) | 1973-08-23 | 1973-08-23 | Phenoxy Amino Probanol |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPS5823399B2 (en) |
| BE (1) | BE818965A (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1235684A (en) * | 1967-11-21 | 1971-06-16 | Ct De Rech S Marcel Midy | Improvements in or relating to nitrogen-containing heterocyclic derivatives |
| US3754003A (en) * | 1971-07-08 | 1973-08-21 | A Pedrazzoli | Tetramethyl pyrrolidine derivatives |
-
1973
- 1973-08-23 JP JP48094977A patent/JPS5823399B2/en not_active Expired
-
1974
- 1974-08-16 BE BE147714A patent/BE818965A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5046657A (en) | 1975-04-25 |
| BE818965A (en) | 1974-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SU850003A3 (en) | Method of preparing hydantoin n-methyl esters | |
| JP5604424B2 (en) | Method for the preparation of proapoptotic agent ABT-263 | |
| NO172342B (en) | PROCEDURE FOR THE PREPARATION OF 2- (2- (4 - ((4-CHLORPHENYL) -PHENYLMETHYL) -1-PIPERAZINYL) -ETHOXY) -DETIC ACID AND ITS DIHYDROCHLORIDE, AND INTERMEDIATE PRODUCT FOR USE BY FRAME | |
| CS196423B2 (en) | Method of producing substituted phenoxy benzylalcohols | |
| JPS61236775A (en) | Manufacture of 1,2-dithiolane-3-pentanoic acid | |
| SU537627A3 (en) | Method for producing morpholine derivatives | |
| DD298911A5 (en) | AZETIDINES, THEIR PREPARATION AND USE AS INTERMEDIATE PRODUCTS FOR THE MANUFACTURE OF BIOLOGICALLY ACTIVE SUBSTANCES | |
| CN104591959B (en) | A kind of preparation method of stilbene compound | |
| JPS5823399B2 (en) | Phenoxy Amino Probanol | |
| JP7252978B2 (en) | Process for preparing 2-(1-(tert-butoxycarbonyl)piperidin-4-yl)benzoic acid | |
| SU664559A3 (en) | Method of obtaining 3-amino-2-oxypropane derivatives or salts thereof | |
| JPS60193940A (en) | Novel aromatic alkene compound | |
| CN103113323B (en) | The preparation method of Lasofoxifene tartrate intermediate | |
| JPS5915901B2 (en) | Method for producing u↓-amino alcohol | |
| CN114853640A (en) | Preparation method of 2-bromoethyl sodium sulfonate | |
| JPS5817193B2 (en) | Phenoxy Amino Probanol | |
| EP0001991B1 (en) | Phosphonium compounds, process for their preparation and process for the preparation of optical brighteners based on asymmetrically substituted stilbenes | |
| JP4725760B2 (en) | Optically active phosphate ester derivatives and uses thereof | |
| JP2013510115A (en) | Method for producing 5-lipoxygenase-activating protein inhibitor and its intermediate | |
| JPH08268984A (en) | Preparation of diphenylamine | |
| US2579500A (en) | N-(phenoxyisopropyl)-n-thenylbeta-halo-ethylamines | |
| KR100712799B1 (en) | Method for preparing 2- [2- (3-methoxyphenyl) ethyl] phenol and its intermediate using palladium catalyst | |
| JP4750286B2 (en) | Method for producing novel biphenyl compound having reactive group | |
| JPS5939417B2 (en) | Method for producing amino alcohol derivatives | |
| JPS59501411A (en) | 2↓-pyrimidylalkanesulfonate and its production and usage methods |